Enterotoxigenic Escherichia Coli
Morphology |
Gram negative rod non-spore forming bacteria |
---|---|
Disease |
Human diarrhea caused by ETEC is the most common disease caused by pathogenic E. coli strains. It is estimated that there are more than 650 million cases of ETEC infection each year. ETEC infections are most common in developing countries that lack appropriate sanitation and drinking-water treatment facilities but are now considered a re-emerging food- and water-borne disease in developed nations as well. In developing nations disease occurs at any time of the year, but incidence peaks in the warm, wet seasons that favor environmental bacterial replication. ETEC is a disease of young children in developing nations. The percentage of ETEC in children with diarrhea varies from 10-30%. In endemic areas, 20–40% of diarrhea cases are due to ETEC. Several studies suggest that 20–60% of travellers from developed countries experience diarrhea when visiting the areas where ETEC infection is endemic. Furthermore, several outbreaks have occurred on cruise ships, which appear to constitute a fairly frequent setting for disease caused by this organism. Outbreaks of ETEC caused by endemic strains, rather than association with travel, have occurred in the U.S. and Denmark. As with travel-associated diarrhea, disease caused by ETEC in developed nations tends to strike older children and adults. |
Zoonosis |
None reported |
Host Range | Humans and animals. |
---|---|
Modes of Transmission
|
Fecal-oral route and are most common in developing countries that lack appropriate
sanitation and drinking water treatment facilities.
|
Signs and Symptoms |
Low grade fever with nausea, diarrhea, and vomiting may be present. Abrupt onset of
watery diarrhea that does not contain blood, pus, or mucus.
|
Infectious Dose | Estimated to be around 100 million organisms. |
Incubation Period |
14 to 30 hours.
|
Prophylaxis | None available. |
---|---|
Vaccines | None available. |
Treatment |
Electrolyte fluid therapy. Susceptible to carbapenem, fosfomycintrometanol, nitrofurantoin,
and bovine apolactoferrin.
|
Surveillance | Monitor for symptoms. |
MSU Requirements | Report any exposures. |
Laboratory Acquired Infections (LAIs) | 12 reported cases. |
---|---|
Sources |
Contaminated food and feces. Cultures, frozen stocks, other samples described in IBC
protocol.
|
Canadian MSDS:
|
http://www.phac-aspc.gc.ca/lab-bio/res/psds-ftss/index-eng.php |
---|---|
BMBL
|
https://www.cdc.gov/labs/BMBL.html |
CDC
|
https://www.cdc.gov/ecoli/etec.html |
NIH Guidelines
|
Risk Group 2
|
Agents that are associated with human disease which is rarely serious and for which preventive or therapeutic interventions are often available. |
---|---|
BSL2
|
For all procedures involving suspected or known infectious specimen or cultures.
|
ABSL2
|
For all procedures utilizing infected animals.
|
Small
|
Notify others working in the lab. Remove PPE and don new PPE. Cover area of the spill
with absorbent material and add fresh 1:10 bleach:water. Allow 20 munutes (or as directed)
of contact time. After 20 minutes, cleanup and dispose of materials.
|
---|---|
Large
|
|
Mucous membrane
|
Flush eyes, mouth, or nose for 5 minutes at eyewash station.
|
---|---|
Other Exposures
|
Wash area with soap and water for 5 minutes.
|
Reporting |
Immediately report incident to supervisor, complete a First Report of Injury form, and submit to Safety and Risk Management.
|
Medical Follow-up
|
During business hours: Bridger Occupational Health 3406 Laramie Drive. Weekdays 8am -6pm. Weekends 9am-5pm
After business hours: Bozeman Deaconess Hospital Emergency Room 915 Highland Blvd Bozeman, MT |
Disinfection |
Susceptible to 1:10 bleach:water, 70 % ethanol, and glutaraldehyde, accelerated hydrogen
peroxide
|
---|---|
Inactivation |
Inactivated moist heat (121°C for 30 min) and dry heat (1 hour at 160-170 C).
|
Survival Outside Host
|
Can survive for 1.5 hours to 16 months on dry inanimate surfaces
|
Minimum PPE Requirements
|
Lab coat, disposable gloves, safety glasses, closed toed shoes, long pants
|
---|---|
Additional Precautions
|
Additioanl PPE may be required depending on lab specific SOPs and IBC Protocol. |